aPTT Test: Normal Ranges, Prolonged & Shortened Results Exp…

aPTT

Coagulación

Última revisión: 7 de abril de 2026. Enfoque de fuentes: contexto estándar de interpretación de laboratorio, material médico de referencia y orientación clínica o de salud pública cuando corresponde.

¿Qué es aPTT?

The aPTT (activated partial thromboplastin time) is a coagulation screening test that measures how long it takes blood to form a clot through the intrinsic and common coagulation pathways. It evaluates the function of clotting factors XII, XI, IX, VIII, X, V, II (prothrombin), and I (fibrinogen). In the laboratory, a blood sample is mixed with a phospholipid reagent, a contact activator (such as kaolin, silica, or ellagic acid), and calcium chloride, and the time to clot formation is recorded in seconds.

The aPTT is one of the most widely ordered coagulation tests, used both for screening bleeding disorders and for monitoring anticoagulation therapy—particularly unfractionated heparin. It is especially sensitive to deficiencies in the intrinsic pathway factors (VIII, IX, XI, XII). When used alongside the prothrombin time (PT/INR), which evaluates the extrinsic pathway, the two tests together help localize which segment of the coagulation cascade is abnormal, guiding further diagnostic workup for bleeding or clotting disorders.

Por qué importa

The aPTT is essential for evaluating the body's ability to form blood clots properly. A prolonged aPTT may indicate a bleeding disorder such as hemophilia A (factor VIII deficiency) or hemophilia B (factor IX deficiency), von Willebrand disease, or the presence of an inhibitor like a lupus anticoagulant. In clinical practice, aPTT is critical for monitoring patients on unfractionated heparin therapy—too little heparin increases clotting risk, while too much increases bleeding risk. The aPTT also serves as a preoperative screening tool to identify unsuspected coagulation abnormalities before surgery.

Rangos de referencia normales

Grupo	Rango	Unidad
Adults	25–35	seconds
Therapeutic heparin range	60–80	seconds
Newborns	31–54	seconds

Los rangos de referencia pueden variar entre laboratorios. Compara siempre tus resultados con los rangos proporcionados por tu laboratorio.

Qué significan los niveles altos de aPTT

Causas comunes

Hemophilia A (factor VIII deficiency) or B (factor IX deficiency)
von Willebrand disease
Unfractionated heparin therapy
Lupus anticoagulant (antiphospholipid syndrome)
Disseminated intravascular coagulation (DIC)
Liver disease (impaired clotting factor production)
Vitamin K deficiency (affects common pathway factors)
Factor XI or XII deficiency
Specific factor inhibitors (antibodies)

Posibles síntomas

Easy bruising
Prolonged bleeding from cuts or dental procedures
Spontaneous nosebleeds (epistaxis)
Heavy menstrual bleeding
Joint bleeding (hemarthrosis)—classic in hemophilia
Blood in urine or stool
Excessive bleeding after surgery or trauma

Qué hacer: A prolonged aPTT requires further investigation with a mixing study—mixing the patient's plasma with normal plasma to determine if the prolongation corrects (suggesting factor deficiency) or persists (suggesting an inhibitor). Based on results, specific factor levels, von Willebrand factor testing, or lupus anticoagulant testing may be ordered. If on heparin, the dose may need adjustment. Severe bleeding may require factor replacement, fresh frozen plasma, or cryoprecipitate.

Qué significan los niveles bajos de aPTT

Causas comunes

Extensive cancer (increased procoagulant activity)
Acute phase response (increased factor VIII as an acute phase reactant)
Early disseminated intravascular coagulation
Elevated factor VIII levels
Technical or sample issues

Posibles síntomas

Usually no direct symptoms from shortened aPTT
May be associated with increased thrombotic risk in some contexts

Qué hacer: A shortened aPTT is less commonly clinically significant but may indicate a hypercoagulable state. Evaluate for thrombotic risk factors, particularly if the patient has a history of blood clots. Check factor VIII levels, as elevated factor VIII is both an acute phase reactant and an independent thrombotic risk factor. Clinical correlation is essential.

¿Cuándo se recomienda la prueba de aPTT?

As a preoperative coagulation screening test
When a bleeding disorder is suspected
To monitor unfractionated heparin therapy
When evaluating unexplained bruising or bleeding
As part of a thrombophilia workup
Before invasive procedures in patients with liver disease

Preguntas frecuentes

The aPTT and PT/INR evaluate different portions of the coagulation cascade. The aPTT tests the intrinsic pathway (factors XII, XI, IX, VIII) and common pathway (X, V, II, fibrinogen), while the PT/INR tests the extrinsic pathway (factor VII) and common pathway. Prolonged aPTT with normal PT suggests an intrinsic pathway problem (e.g., hemophilia), while prolonged PT with normal aPTT suggests an extrinsic pathway issue (e.g., warfarin therapy or factor VII deficiency). If both are prolonged, the common pathway or multiple factors are affected.

Unfractionated heparin primarily enhances antithrombin activity against factors in the intrinsic and common pathways—the very factors that aPTT measures—making it the ideal monitoring tool. Warfarin, on the other hand, inhibits the vitamin K–dependent factors (II, VII, IX, X), and factor VII in the extrinsic pathway is affected earliest and most significantly, so the PT/INR is the appropriate monitoring test for warfarin. Low-molecular-weight heparins (like enoxaparin) do not reliably prolong the aPTT and are monitored with anti-Xa activity levels when monitoring is needed.

Yes, this is one of the most counterintuitive findings in hematology. A lupus anticoagulant prolongs the aPTT in the laboratory because it interferes with the phospholipid-dependent clotting reaction in the test tube. However, in the body, lupus anticoagulant is actually associated with an increased risk of thrombosis (blood clots), not bleeding. This is because the antibodies activate platelets and endothelial cells in vivo. A prolonged aPTT that does not correct with a mixing study, combined with a history of blood clots or pregnancy complications, raises suspicion for antiphospholipid syndrome.

Biomarcadores relacionados

aPTTActivated Partial Thromboplastin Time PT/INRTiempo de protrombina FibFibrinógeno

Referencias y enfoque de revisión

Las páginas del glosario de biomarcadores son explicaciones educativas y deben interpretarse junto con los rangos de referencia y comentarios proporcionados por tu laboratorio y tu profesional de salud. Para conocer nuestros estándares editoriales y proceso de revisión, consulta nuestra Política editorial y nuestro Proceso de revisión de contenido.

¿Quieres analizar tus niveles de aPTT?

Sube tus resultados de laboratorio para recibir un análisis instantáneo con IA de todos tus biomarcadores.

Subir resultados de laboratorio →

Aviso médico: Esta información es solo educativa y no sustituye el consejo, diagnóstico ni tratamiento médico profesional. Los rangos de referencia pueden variar entre laboratorios. Consulta siempre a tu profesional sanitario para interpretar tus resultados concretos.